Literature DB >> 3690540

Phase II study on oral N-methylformamide in metastatic colorectal cancer.

A S Planting1, J G Klijn, J Verweij, G Stoter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3690540

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  N-methylformamide affects spontaneous metastases of 3LL lines and increases natural killer activity of tumor-bearing mice.

Authors:  C Greco; D Del Bufalo; D Giannarelli; M Marangolo; M P Fuggetta; E Bonmassar; G Zupi
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

2.  Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.

Authors:  G Arancia; C Leonetti; W Malorni; C Greco; G Formisano; M Marangolo; G Zupi
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.

Authors:  E K Rowinsky; L B Grochow; A Hantel; D S Ettinger; B L Vito; R C Donehower
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.